GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GHRS is expected to report earnings to rise 3.23% to -31 cents per share on August 26
Q2'26
Est.
$-0.32
Q1'26
Missed
by $0.02
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.06
The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 140.21K shares outstanding, the current market capitalization sits at 1.68B.